Saturday 17 October 2026
Export ACAD’s income statement to Excel — free account
ACADIA Pharmaceuticals Inc.
ACAD Healthcare Biotechnology
ACADIA Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 11.9% from fiscal 2024. In the quarter to June 2026, revenue grew 16.4%, EPS grew 12.5% and free cash flow grew 50.3%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.
19.12
0.59
−2.99%
Follow ACAD
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 35.74% | 37.32% | 39.89% | 34.95% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
5 | 5 | 6 | 6 | |
| 25.64% | 27.44% | 28.42% | 22.64% | ||
ROIC |
15.42% | 12.75% | 16.07% | 214.34% | |
Return on Tangible Assets |
43.23% | 46.66% | 49.34% | 36.10% | |
Average Days of Receivables |
53.32 | 49.45 | 50.49 | 48.60 | |
Free Cash Flow per Share |
0.85 | 0.67 | 0.62 | 0.00 | |
Free Cash Flow |
145.63 | 113.59 | 104.69 | 0.06 | |
Capital Expenditures |
(14.69) | (9.90) | (5.14) | (198.88) | |
| Other line items | |||||
Cash ROIC |
6.43% | 5.41% | 5.11% | 0.00% | |
Accounts Receivable Turnover |
7.96 | 8.36 | 8.47 | 8.38 | |
Accounts Payable Turnover |
3.12 | 6.16 | 6.57 | 4.14 | |
Inventory Turnover |
3.45 | 3.43 | 3.14 | 1.88 | |
Average Days of Payables |
161.09 | 47.86 | 44.72 | 93.85 | |
Days of Inventory on Hand |
117.01 | 123.39 | 142.19 | 125.57 | |
Tax Rate |
2.14 | 2.26 | 1.81 | (0.05) | |
Research and Development Expense of Revenue |
29.07% | 29.89% | 30.69% | 32.93% | |
Selling, General and Administrative Expense of Revenue |
54.48% | 54.19% | 51.23% | 49.98% | |
Share Based Compensation of Revenue |
5.10% | 5.06% | 4.87% | 4.71% | |
Operating CF/Net income |
0.42 | 0.33 | 0.28 | 0.76 | |
Depreciation/Fixed assets |
0.57 | 0.55 | 0.84 | 1.75 | |
Capex/Depreciation |
(1.51) | (1.23) | (0.81) | (30.70) | |
Revenue per Share |
6.64 | 6.42 | 6.36 | 6.20 | |
Operating CF per Share |
0.93 | 0.72 | 0.65 | 1.18 | |
Capex per Share |
(0.09) | (0.06) | (0.03) | (1.18) | |
Capex to Sales |
0.01 | 0.01 | 0.00 | 0.19 |
Columns are period end dates